InvestorsHub Logo
icon url

Saltz

03/28/20 12:52 PM

#60761 RE: Andy2018 #60756

I am very aware of what is going on.

First of all Leronlimab is for last stage Covid-19 respiratory failure. It’s huge because it may be the answer to saving the very sick. It is on the other hand not a vaccine. Monetizing is going to be tricky given the limited long term demand as the Covid -19 curve is going to flatten. Also COGS for Leronlimab at largest scale is still expensive.

Don’t get me wrong I am very excited about what I see going on with saving these very sick people, however our long term play is HIV and Cancer.

This is going to give us incredible exposure and hopefully a big lift in SP. We need to take advantage of this opportunity and nail down a significant partner and licensing deal to get to the goal line with the meat which is HIV and Cancer.

AIMHO